#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Retinitis pigmentosa Vascular calcification Progressive familial intrahepatic cholestasis Paraneoplastic neurological syndrome Erythema Breast cancer metastatic Systemic candida Squamous cell carcinoma of the oral cavity Congenital absence of bile ducts Chronic kidney disease Ovarian cancer stage III Dermatitis Diffuse large B-cell lymphoma refractory Paget's disease of the vulva Squamous cell carcinoma of the hypopharynx More trials…

    Learn about Rare Diseases

    Myelodysplastic syndrome with excess blasts – Diagnostics VEXAS syndrome – Life with Disease Cholangitis sclerosing – Life with Disease Methylmalonic acidaemia – Trials in Disease Hereditary angioedema with C1 esterase inhibitor deficiency – Life with Disease Encephalitis autoimmune – Life with Disease Hairy cell leukaemia recurrent Alveolar rhabdomyosarcoma – Diagnostics Primary mediastinal large B-cell lymphoma – Diagnostics Primary biliary cholangitis More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ezetimibe F1245/05 Xp-Dc+Tl+Klh Deucravacitinib Ima402 Bi 765845 Anifrolumab TAZAROTENE Bisoprolol Fumarate Adalimumab F125/10 Paclitaxel Enzalutamide Vericiguat Epinephrine Hydrochloride Frexalimab Aavanc80-3'Hotof 7-Ethyl-10-Hydroxycamptothecin Mbf-015 Everolimus More therapies…

    Learn about Your Condition

    Monkeypox White matter lesion Transferrin decreased Urethral valves Hypoglycaemia Haemofiltration Angiopathy Gastrointestinal carcinoma Aicardi-Goutieres syndrome Netherton's syndrome Alveolar bone defect Gastrectomy Liver transplant rejection Post procedural swelling Graft versus host disease More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Hospitalier Victor Dupouy

Centre Hospitalier Victor Dupouy

69 Rue Du Lieutenant Colonel Prudhon, Argenteuil, 95107, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study Comparing Rivaroxaban and Drug Combination for Preventing Blood Clots in Patients with Lower Limb Injuries Requiring Immobilization

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Joint stabilisation
    Investigated Drugs:
    • Rivaroxaban
    • Dalteparin Sodium
    • Enoxaparin Sodium
    France

  • Study on the Effectiveness of Chemotherapy with Folinic Acid, Fluorouracil, and Irinotecan for Patients with Stage III Colon Cancer After Surgery

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Colon cancer
    Investigated Drugs:
    • Bevacizumab
    • Fluorouracil
    • Folinic Acid
    France

  • Study Comparing Odronextamab with Rituximab and Chemotherapy for Patients with Untreated Follicular Lymphoma

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Odronextamab
    • Bendamustine Hydrochloride
    • Cyclophosphamide
    Austria Belgium Czechia France Germany Italy +2

  • Study on the Benefits of Autologous Stem Cell Transplantation for Patients with Peripheral T-cell Lymphoma Using Etoposide and Drug Combination

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Peripheral T-cell lymphoma unspecified
    Investigated Drugs:
    • Methylprednisolone Hemisuccinate
    • Brentuximab Vedotin
    • Cyclophosphamide Monohydrate
    Belgium France

  • Study of Trimodulin for Adults Hospitalized with Severe Community-Acquired Pneumonia

    Recruiting

    3 1
    Investigated Diseases:
    • Pneumonia
    Investigated Drugs:
    • Trimodulin (Human Igm, Iga, Igg Solution)
    Austria Belgium Czechia France Germany Hungary +3

  • Study of Camizestrant for Patients with ER+/HER2- Early Breast Cancer After 2 Years of Standard Endocrine Therapy

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Goserelin
    • Leuprorelin
    • Triptorelin
    Austria Belgium Bulgaria Czechia France Germany +8

  • Study on Luspatercept and Epoetin Alfa for Patients with Low-Risk Myelodysplastic Syndrome Without Ring Sideroblasts Who Did Not Respond to ESA

    Recruiting

    1 1 1 1
    Investigated Drugs:
    • Epoetin Alfa
    • Luspatercept
    France Italy

  • Study on Maintenance Treatment with Pembrolizumab and Pemetrexed for Stage IV Non-Small Cell Lung Cancer Patients After Initial Chemotherapy and Immunotherapy

    Recruiting

    4 1 1 1
    Investigated Drugs:
    • Carboplatin
    • Cisplatin
    • Paclitaxel
    France

  • Study on Blinatumomab, Ponatinib, and Isatuximab for Adults Aged 18-65 with Newly Diagnosed Acute Lymphoblastic Leukemia or T-Cell Lymphoblastic Lymphoma

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Lymphocytic leukaemia
    • Acute lymphocytic leukaemia
    Investigated Drugs:
    • Ponatinib
    • Blinatumomab
    • Isatuximab
    Belgium France

  • Study of nemtabrutinib combined with venetoclax and obinutuzumab in untreated CLL/SLL patients with TP53 alterations

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Nemtabrutinib
    • Obinutuzumab
    • Venetoclax
    France
Previous Page
1 2 3 4 5 … 9
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!